GLOBAL ETHICAL PHARMACEUTICALS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)
Global Ethical Pharmaceuticals Market, By Therapeutic Class (Hormonal Contraceptives, Respiratory Agents, Lipid Regulators, Calcium Antagonists, ACE Inhibitors, Narcotic Analgesics, Others), By End User (Hospitals & Clinics, Pharmaceutical Companies, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).
In November 2023, AstraZeneca, a biopharmaceutical company, announced that Truqap (capivasertib) in combination with Faslodex (fulvestrant) is now approved in the U.S. for the treatment of adult patients with hormone receptor (HR)-positive, HER2-negative locally advanced or metastatic breast cancer with one or more biomarker alterations.
In October 2023, Pfizer Inc., a biopharmaceutical company, announced that the U.S. has approved VELSIPITY (etrasimod), an oral, once-daily, selective sphingosine-1-phosphate (S1P) receptor modulator for people with moderately to severely active ulcerative colitis. The approved recommended dose of VELSIPITY is 2 mg.
In February 2023, the U.S. FDA approved ALTUVIIIO [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl], formerly known as efanesoctocog alfa, a first-in-class, high-sustained factor VIII replacement therapy. ALTUVIIIO is recommended for routine prophylaxis and on-demand treatment to control bleeding episodes, as well as perioperative care (surgery) in adults and children with hemophilia A.
In November 2020, com, Inc., an online pharmacy store, launched two new pharmacy options to assist customers in purchasing their prescription prescriptions. Amazon pharmaceutical, a new Amazon store, enables users to conduct their pharmaceutical transactions on their desktop or mobile device via the Amazon App. Customers can use a secure pharmacy profile to input insurance information, manage prescriptions, and select payment methods before checking out.
Global Ethical Pharmaceuticals Market Report Snapshots